Intravenous Immunoglobulin After Relapse in Vasculitis

NCT00307658 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

ANCA + Vasculitides Relapsing Either Under Corticosteroid
and Immunosuppressant Therapies or After One Year
Post Treatment.

Interventions

DRUG: Intravenous immunoglobulins (human immunoglobulins G)

Sponsor

Assistance Publique - Hôpitaux de Paris